RecruitingNCT05890092
Vulvar Disease in Nigeria Observational Study
Vulvar Disease in Nigeria - Registry ( Observationsl Study)
Sponsor
KDRS ltd
Enrollment
1,000 participants
Start Date
May 3, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria
Eligibility
Sex: FEMALEMin Age: 10 YearsMax Age: 90 Years
Inclusion Criteria1
- biological females - afab
Exclusion Criteria1
- none-afab
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERObservation
Observing for disease prevalence - actual and self-reported
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05890092
Related Trials
Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.
NCT069623451 location
Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
NCT060704541 location
Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)
NCT060752645 locations
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
NCT0559262632 locations
Clinical and Molecular Study to Evaluate the Effect of the Pixel CO2 Laser (FemiLiftTM) for the Treatment of Vulvo-Vaginal Atrophy
NCT070246671 location